What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.46%Above 5Y avg (2.15%)
Annual Rate
TRY 6.83Paid annual
Payout Ratio
99.9%High
Payback Period
28.2 yr
Last Ex-Dividend
Mar 25, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
500.66BTRY
10.07B · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
29.09x
vs Conglomerates peers
Updated Oct 25, 2026
Revenue (TTM)
2.90TTRY
58.24B · vs all stocks (USD)
Updated Oct 25, 2026
Profit Margin
1.94%
vs Conglomerates peers
Updated Oct 25, 2026
Beta
0.2700x
vs all stocks
Updated Oct 25, 2026
52-Week Change
17.35%
vs all stocks
Updated Oct 25, 2026
Market Capitalization
500.66BTRY
10.07B · vs all stocks (USD)
Updated Oct 25, 2026
Enterprise Value
2.05TTRY
41.18B · vs all stocks (USD)
Updated Oct 25, 2026
Trailing P/E
29.09x
vs Conglomerates peers
Updated Oct 25, 2026
Forward P/E
6.61x
vs Conglomerates peers
Updated Oct 25, 2026
PEG Ratio
0.1872x
vs Conglomerates peers
Updated Oct 25, 2026
Price to Sales (TTM)
0.1729x
vs Conglomerates peers
Updated Oct 25, 2026
Price to Book (MRQ)
0.6316x
vs Conglomerates peers
Updated Oct 25, 2026
Enterprise to Revenue
0.7070x
vs Conglomerates peers
Updated Oct 25, 2026
Enterprise to EBITDA
10.21x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 7.03×.Updated Oct 25, 2026
Gross Margin
18.46%
vs Conglomerates peers
Updated Oct 25, 2026
Profit Margin
1.94%
vs Conglomerates peers
Updated Oct 25, 2026
Operating Margin
6.44%
vs Conglomerates peers
Updated Oct 25, 2026
Return on Assets (TTM)
1.60%
vs Conglomerates peers
Updated Oct 25, 2026
Return on Equity (TTM)
6.12%
vs Conglomerates peers
Updated Oct 25, 2026
Revenue (TTM)
2.90TTRY
58.24B · vs all stocks (USD)
Updated Oct 25, 2026
Revenue per Share (TTM)
1.14KTRYUpdated Oct 25, 2026
Quarterly Revenue Growth
12.80%
vs Conglomerates peers
Updated Oct 25, 2026
Gross Profit (TTM)
509.36BTRY
10.24B · vs all stocks (USD)
Updated Oct 25, 2026
EBITDA (TTM)
291.24BTRY
5.86B · vs all stocks (USD)
Updated Oct 25, 2026
Net Income (TTM)
56.28BTRY
1.13B · vs all stocks (USD)
Updated Oct 25, 2026
Quarterly Earnings Growth (YoY)
166.10%
vs Conglomerates peers
Updated Oct 25, 2026
Operating Cash Flow (TTM)
-44.26BTRY
-890.20M · vs all stocks (USD)
Updated Oct 25, 2026
Levered Free Cash Flow (TTM)
37.90BTRY
762.33M · vs all stocks (USD)
Updated Oct 25, 2026
Trailing Annual Dividend Rate
6.83TRYUpdated Oct 25, 2026
Trailing Annual Dividend Yield
3.46%
vs all stocks
Updated Oct 25, 2026
5-Year Average Dividend Yield
2.15%
vs all stocks
Updated Oct 25, 2026
Payout Ratio
99.89%
vs Conglomerates peers
Updated Oct 25, 2026
Minority Interest (Equity)
415.22BTRYFY2025 · Dec 31, 2025
Revenue
2.76TTRYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.29TTRYFY2025 · Dec 31, 2025
Gross Profit
469.35BTRYFY2025 · Dec 31, 2025
Operating Income
104.09BTRY
2.09B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
87.71BTRYFY2025 · Dec 31, 2025
Income Tax Expense
53.09BTRYFY2025 · Dec 31, 2025
Net Income
34.63BTRYFY2025 · Dec 31, 2025
EBIT
160.64BTRYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
238.95BTRYFY2025 · Dec 31, 2025
Research & Development
9.38BTRYFY2025 · Dec 31, 2025
Selling, General & Administrative
161.61BTRYFY2025 · Dec 31, 2025
Other Operating Expenses
40.35BTRYFY2025 · Dec 31, 2025
Non-operating Interest Income
57.02BTRYFY2025 · Dec 31, 2025
Non-operating Interest Expense
72.93BTRYFY2025 · Dec 31, 2025
EPS (Basic)
8.68TRYFY2025 · Dec 31, 2025
EPS (Diluted)
8.68TRYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.54BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.54BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
34.63BTRYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-12.63BTRYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025
Operating Cash Flow
-178.34BTRYFY2025 · Dec 31, 2025
Free Cash Flow
-250.16BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
580.76BTRYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
34.63BTRYFY2025 · Dec 31, 2025
Other Non-cash Items
-172.00MTRYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-242.22BTRYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
29.43BTRYFY2025 · Dec 31, 2025
Capital Expenditures
-71.82BTRYFY2025 · Dec 31, 2025
Net Acquisitions
-8.98BTRYFY2025 · Dec 31, 2025
Purchase of Investments
-4.30BTRYFY2025 · Dec 31, 2025
Other Investing Activity
-105.99BTRYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-191.08BTRYFY2025 · Dec 31, 2025
Long-term Debt Issuance
856.57BTRYFY2025 · Dec 31, 2025
Long-term Debt Payments
-499.71BTRYFY2025 · Dec 31, 2025
Common Dividends Paid
-41.84BTRYFY2025 · Dec 31, 2025
Other Financing Charges
29.39BTRYFY2025 · Dec 31, 2025
Net Financing Cash Flow
344.40BTRYFY2025 · Dec 31, 2025
Shares Outstanding
2.54BSharesUpdated Oct 25, 2026
Float Shares
188.05MSharesUpdated Oct 25, 2026
% Held by Insiders
57.19%
vs all stocks
Updated Oct 25, 2026
% Held by Institutions
9.02%
vs all stocks
Updated Oct 25, 2026
Total Cash (MRQ)
541.50BTRY
10.89B · vs all stocks (USD)
Updated Oct 25, 2026
Total Cash per Share (MRQ)
213.61TRYUpdated Oct 25, 2026
Total Debt (MRQ)
1.59TTRY
31.96B · vs all stocks (USD)
Updated Oct 25, 2026
Total Debt to Equity (MRQ)
1.23x
vs Conglomerates peers
Updated Oct 25, 2026
Current Ratio (MRQ)
0.9050x
vs Conglomerates peers
Updated Oct 25, 2026
Book Value per Share (MRQ)
312.68TRYUpdated Oct 25, 2026
Total Assets
5.32TTRY
106.95B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.02TTRYFY2025 · Dec 31, 2025
Total Liabilities
4.23TTRYFY2025 · Dec 31, 2025
Total Non-current Assets
2.30TTRYFY2025 · Dec 31, 2025
Total Non-current Liabilities
765.42BTRYFY2025 · Dec 31, 2025
Total Current Liabilities
3.46TTRYFY2025 · Dec 31, 2025
Cash
123.75BTRYFY2025 · Dec 31, 2025
Cash Equivalents
235.08BTRYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
358.83BTRYFY2025 · Dec 31, 2025
Other Short-term Investments
324.03BTRYFY2025 · Dec 31, 2025
Accounts Receivable
240.07BTRYFY2025 · Dec 31, 2025
Inventory
195.09BTRYFY2025 · Dec 31, 2025
Accounts Payable
295.44BTRYFY2025 · Dec 31, 2025
Short-term Debt
902.36BTRYFY2025 · Dec 31, 2025
Other Current Liabilities
131.58BTRYFY2025 · Dec 31, 2025
Long-term Debt
601.54BTRYFY2025 · Dec 31, 2025
Other Non-current Liabilities
9.37BTRYFY2025 · Dec 31, 2025
Common Stock (Book)
2.54BTRYFY2025 · Dec 31, 2025
Retained Earnings
617.07BTRYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.09TTRY
21.97B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
118.00MTRYFY2025 · Dec 31, 2025
52-Week Low
159.00TRYUpdated Oct 25, 2026
52-Week High
232.50TRYUpdated Oct 25, 2026
52-Week Change
17.35%
vs all stocks
Updated Oct 25, 2026
Beta
0.2700x
vs all stocks
Updated Oct 25, 2026
50-Day MA
213.91TRYUpdated Oct 25, 2026
200-Day MA
202.06TRYUpdated Oct 25, 2026
Avg 10-Day Volume
20.14MSharesUpdated Oct 25, 2026
Avg 30-Day Volume
24.29MSharesUpdated Oct 25, 2026
Diluted EPS (TTM)
6.79TRYUpdated Oct 25, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.